ID   PYGL_HUMAN              Reviewed;         847 AA.
AC   P06737; A6NDQ4; B4DUB7; F5H816; O60567; O60752; O60913; Q501V9;
AC   Q641R5; Q96G82;
DT   01-JAN-1988, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   10-MAY-2017, entry version 203.
DE   RecName: Full=Glycogen phosphorylase, liver form;
DE            EC=2.4.1.1;
GN   Name=PYGL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT PRO-425.
RC   TISSUE=Liver;
RX   PubMed=2877458; DOI=10.1073/pnas.83.21.8132;
RA   Newgard C.B., Nakano K., Hwang P.K., Fletterick R.J.;
RT   "Sequence analysis of the cDNA encoding human liver glycogen
RT   phosphorylase reveals tissue-specific codon usage.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:8132-8136(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RA   Carty M.D., Clancy Y.C., Soeller W.C.;
RL   Submitted (MAY-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9536091; DOI=10.1093/hmg/7.5.865;
RA   Chang S., Rosenberg M.J., Morton H., Francomano C.A., Biesecker L.G.;
RT   "Identification of a mutation in liver glycogen phosphorylase in
RT   glycogen storage disease type VI.";
RL   Hum. Mol. Genet. 7:865-870(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANTS GSD6 SER-339 AND
RP   LYS-377, AND VARIANT ILE-222.
RC   TISSUE=Blood;
RX   PubMed=9529348; DOI=10.1086/301790;
RA   Burwinkel B., Bakker H.D., Herschkovitz E., Moses S.W., Shin Y.S.,
RA   Kilimann M.W.;
RT   "Mutations in the liver glycogen phosphorylase gene 'PYGL' underlying
RT   glycogenosis type VI.";
RL   Am. J. Hum. Genet. 62:785-791(1998).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   SER-845.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta, Skin, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 482-847 (ISOFORM 1).
RC   TISSUE=Fetal brain;
RX   PubMed=3509980;
RA   Gorin F.A., Mullinax R.L., Ignacio P.C., Neve R.L., Kurnit D.M.;
RT   "McArdle's & Hers' diseases: glycogen phosphorylase transcriptional
RT   expression in human tissues.";
RL   J. Neurogenet. 4:293-308(1987).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-639, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS).
RX   PubMed=10980448; DOI=10.1016/S1074-5521(00)00004-1;
RA   Rath V.L., Ammirati M., Danley D.E., Ekstrom J.L., Gibbs E.M.,
RA   Hynes T.R., Mathiowetz A.M., McPherson R.K., Olson T.V.,
RA   Treadway J.L., Hoover D.J.;
RT   "Human liver glycogen phosphorylase inhibitors bind at a new
RT   allosteric site.";
RL   Chem. Biol. 7:677-682(2000).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS), AND PHOSPHORYLATION AT SER-15.
RX   PubMed=10949035; DOI=10.1016/S1097-2765(05)00006-7;
RA   Rath V.L., Ammirati M., LeMotte P.K., Fennell K.F., Mansour M.N.,
RA   Danley D.E., Hynes T.R., Schulte G.K., Wasilko D.J., Pandit J.;
RT   "Activation of human liver glycogen phosphorylase by alteration of the
RT   secondary structure and packing of the catalytic core.";
RL   Mol. Cell 6:139-148(2000).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS).
RX   PubMed=12204691; DOI=10.1016/S1074-5521(02)00186-2;
RA   Ekstrom J.L., Pauly T.A., Carty M.D., Soeller W.C., Culp J.,
RA   Danley D.E., Hoover D.J., Treadway J.L., Gibbs E.M., Fletterick R.J.,
RA   Day Y.S., Myszka D.G., Rath V.L.;
RT   "Structure-activity analysis of the purine binding site of human liver
RT   glycogen phosphorylase.";
RL   Chem. Biol. 9:915-924(2002).
CC   -!- FUNCTION: Phosphorylase is an important allosteric enzyme in
CC       carbohydrate metabolism. Enzymes from different sources differ in
CC       their regulatory mechanisms and in their natural substrates.
CC       However, all known phosphorylases share catalytic and structural
CC       properties.
CC   -!- CATALYTIC ACTIVITY: ((1->4)-alpha-D-glucosyl)(n) + phosphate =
CC       ((1->4)-alpha-D-glucosyl)(n-1) + alpha-D-glucose 1-phosphate.
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC   -!- ENZYME REGULATION: Activity of phosphorylase is controlled both by
CC       allosteric means (through the noncovalent binding of metabolites)
CC       and by covalent modification. Thus AMP allosterically activates,
CC       whereas ATP, ADP, and glucose-6-phosphate allosterically inhibit,
CC       phosphorylase B.
CC   -!- SUBUNIT: Homodimer. Dimers associate into a tetramer to form the
CC       enzymatically active phosphorylase A. Interacts with PPP1R3B (By
CC       similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       P11216:PYGB; NbExp=8; IntAct=EBI-2511865, EBI-1047231;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P06737-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P06737-2; Sequence=VSP_045339;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: Phosphorylation of Ser-15 converts phosphorylase B
CC       (unphosphorylated) to phosphorylase A.
CC       {ECO:0000269|PubMed:10949035}.
CC   -!- DISEASE: Glycogen storage disease 6 (GSD6) [MIM:232700]: A
CC       metabolic disorder characterized by mild to moderate hypoglycemia,
CC       mild ketosis, growth retardation, and prominent hepatomegaly.
CC       Heart and skeletal muscle are not affected.
CC       {ECO:0000269|PubMed:9529348}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the glycogen phosphorylase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M14636; AAA52577.1; -; mRNA.
DR   EMBL; AF066858; AAC17450.1; -; mRNA.
DR   EMBL; AF046798; AAC18079.1; -; Genomic_DNA.
DR   EMBL; AF046787; AAC18079.1; JOINED; Genomic_DNA.
DR   EMBL; AF046788; AAC18079.1; JOINED; Genomic_DNA.
DR   EMBL; AF046789; AAC18079.1; JOINED; Genomic_DNA.
DR   EMBL; AF046790; AAC18079.1; JOINED; Genomic_DNA.
DR   EMBL; AF046791; AAC18079.1; JOINED; Genomic_DNA.
DR   EMBL; AF046792; AAC18079.1; JOINED; Genomic_DNA.
DR   EMBL; AF046793; AAC18079.1; JOINED; Genomic_DNA.
DR   EMBL; AF046794; AAC18079.1; JOINED; Genomic_DNA.
DR   EMBL; AF046795; AAC18079.1; JOINED; Genomic_DNA.
DR   EMBL; AF046796; AAC18079.1; JOINED; Genomic_DNA.
DR   EMBL; AF046797; AAC18079.1; JOINED; Genomic_DNA.
DR   EMBL; AF046785; AAC23504.1; -; mRNA.
DR   EMBL; Y15233; CAA75517.1; -; mRNA.
DR   EMBL; AK300580; BAG62279.1; -; mRNA.
DR   EMBL; AL358334; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471078; EAW65685.1; -; Genomic_DNA.
DR   EMBL; BC009895; AAH09895.3; -; mRNA.
DR   EMBL; BC082229; AAH82229.2; -; mRNA.
DR   EMBL; BC095850; AAH95850.2; -; mRNA.
DR   EMBL; BC110791; AAI10792.2; -; mRNA.
DR   EMBL; M36807; AAA35906.1; -; mRNA.
DR   CCDS; CCDS32080.1; -. [P06737-1]
DR   CCDS; CCDS53894.1; -. [P06737-2]
DR   PIR; A25518; A25518.
DR   RefSeq; NP_001157412.1; NM_001163940.1. [P06737-2]
DR   RefSeq; NP_002854.3; NM_002863.4. [P06737-1]
DR   UniGene; Hs.282417; -.
DR   PDB; 1EM6; X-ray; 2.20 A; A/B=1-847.
DR   PDB; 1EXV; X-ray; 2.40 A; A/B=1-847.
DR   PDB; 1FA9; X-ray; 2.40 A; A=2-847.
DR   PDB; 1FC0; X-ray; 2.40 A; A/B=2-847.
DR   PDB; 1L5Q; X-ray; 2.25 A; A/B=1-847.
DR   PDB; 1L5R; X-ray; 2.10 A; A/B=1-847.
DR   PDB; 1L5S; X-ray; 2.10 A; A/B=1-847.
DR   PDB; 1L7X; X-ray; 2.30 A; A/B=1-847.
DR   PDB; 1XOI; X-ray; 2.10 A; A/B=2-847.
DR   PDB; 2ATI; X-ray; 1.90 A; A/B=2-847.
DR   PDB; 2QLL; X-ray; 2.56 A; A=1-847.
DR   PDB; 2ZB2; X-ray; 2.45 A; A/B=1-847.
DR   PDB; 3CEH; X-ray; 2.80 A; A/B=24-832.
DR   PDB; 3CEJ; X-ray; 3.30 A; A/B=24-832.
DR   PDB; 3CEM; X-ray; 2.47 A; A/B=24-832.
DR   PDB; 3DD1; X-ray; 2.57 A; A/B=2-847.
DR   PDB; 3DDS; X-ray; 1.80 A; A/B=2-847.
DR   PDB; 3DDW; X-ray; 1.90 A; A/B=2-847.
DR   PDBsum; 1EM6; -.
DR   PDBsum; 1EXV; -.
DR   PDBsum; 1FA9; -.
DR   PDBsum; 1FC0; -.
DR   PDBsum; 1L5Q; -.
DR   PDBsum; 1L5R; -.
DR   PDBsum; 1L5S; -.
DR   PDBsum; 1L7X; -.
DR   PDBsum; 1XOI; -.
DR   PDBsum; 2ATI; -.
DR   PDBsum; 2QLL; -.
DR   PDBsum; 2ZB2; -.
DR   PDBsum; 3CEH; -.
DR   PDBsum; 3CEJ; -.
DR   PDBsum; 3CEM; -.
DR   PDBsum; 3DD1; -.
DR   PDBsum; 3DDS; -.
DR   PDBsum; 3DDW; -.
DR   ProteinModelPortal; P06737; -.
DR   SMR; P06737; -.
DR   BioGrid; 111794; 41.
DR   IntAct; P06737; 13.
DR   MINT; MINT-1208599; -.
DR   STRING; 9606.ENSP00000216392; -.
DR   BindingDB; P06737; -.
DR   ChEMBL; CHEMBL2568; -.
DR   DrugBank; DB02320; 1-N-Acetyl-Beta-D-Glucosamine.
DR   DrugBank; DB03288; 5-Chloro-1h-Indole-2-Carboxylic Acid{[Cyclopentyl-(2-Hydroxy-Ethyl)-Carbamoyl]-Methyl}-Amide.
DR   DrugBank; DB00131; Adenosine monophosphate.
DR   DrugBank; DB02379; Beta-D-Glucose.
DR   DrugBank; DB02089; CP-526423.
DR   DrugBank; DB07968; N-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA.
DR   DrugBank; DB04522; Phosphonoserine.
DR   DrugBank; DB05044; PSN357.
DR   DrugBank; DB00114; Pyridoxal Phosphate.
DR   DrugBank; DB08844; Uric Acid.
DR   CAZy; GT35; Glycosyltransferase Family 35.
DR   iPTMnet; P06737; -.
DR   PhosphoSitePlus; P06737; -.
DR   BioMuta; PYGL; -.
DR   DMDM; 6648082; -.
DR   EPD; P06737; -.
DR   MaxQB; P06737; -.
DR   PaxDb; P06737; -.
DR   PeptideAtlas; P06737; -.
DR   PRIDE; P06737; -.
DR   DNASU; 5836; -.
DR   Ensembl; ENST00000216392; ENSP00000216392; ENSG00000100504. [P06737-1]
DR   Ensembl; ENST00000544180; ENSP00000443787; ENSG00000100504. [P06737-2]
DR   GeneID; 5836; -.
DR   KEGG; hsa:5836; -.
DR   UCSC; uc001wyu.4; human. [P06737-1]
DR   CTD; 5836; -.
DR   DisGeNET; 5836; -.
DR   GeneCards; PYGL; -.
DR   HGNC; HGNC:9725; PYGL.
DR   HPA; HPA000962; -.
DR   HPA; HPA004119; -.
DR   MalaCards; PYGL; -.
DR   MIM; 232700; phenotype.
DR   MIM; 613741; gene.
DR   neXtProt; NX_P06737; -.
DR   OpenTargets; ENSG00000100504; -.
DR   Orphanet; 369; Glycogen storage disease due to liver glycogen phosphorylase deficiency.
DR   PharmGKB; PA34068; -.
DR   eggNOG; KOG2099; Eukaryota.
DR   eggNOG; COG0058; LUCA.
DR   GeneTree; ENSGT00390000016886; -.
DR   HOVERGEN; HBG006848; -.
DR   InParanoid; P06737; -.
DR   KO; K00688; -.
DR   OMA; KRAWAEF; -.
DR   OrthoDB; EOG091G03RB; -.
DR   PhylomeDB; P06737; -.
DR   TreeFam; TF300309; -.
DR   BioCyc; MetaCyc:HS02099-MONOMER; -.
DR   BRENDA; 2.4.1.1; 2681.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-70221; Glycogen breakdown (glycogenolysis).
DR   SIGNOR; P06737; -.
DR   ChiTaRS; PYGL; human.
DR   EvolutionaryTrace; P06737; -.
DR   GenomeRNAi; 5836; -.
DR   PRO; PR:P06737; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000100504; -.
DR   CleanEx; HS_PYGL; -.
DR   ExpressionAtlas; P06737; baseline and differential.
DR   Genevisible; P06737; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:0016208; F:AMP binding; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0032052; F:bile acid binding; IDA:UniProtKB.
DR   GO; GO:0008144; F:drug binding; IDA:UniProtKB.
DR   GO; GO:0005536; F:glucose binding; NAS:UniProtKB.
DR   GO; GO:0008184; F:glycogen phosphorylase activity; IDA:MGI.
DR   GO; GO:0042803; F:protein homodimerization activity; NAS:UniProtKB.
DR   GO; GO:0002060; F:purine nucleobase binding; IDA:UniProtKB.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IBA:GO_Central.
DR   GO; GO:0019842; F:vitamin binding; IDA:UniProtKB.
DR   GO; GO:0006015; P:5-phosphoribose 1-diphosphate biosynthetic process; IEA:Ensembl.
DR   GO; GO:0042593; P:glucose homeostasis; IMP:UniProtKB.
DR   GO; GO:0005980; P:glycogen catabolic process; IBA:GO_Central.
DR   GO; GO:0005977; P:glycogen metabolic process; IMP:UniProtKB.
DR   GO; GO:0070266; P:necroptotic process; IEA:Ensembl.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   CDD; cd04300; GT1_Glycogen_Phosphorylase; 1.
DR   InterPro; IPR011833; Glycg_phsphrylas.
DR   InterPro; IPR000811; Glyco_trans_35.
DR   PANTHER; PTHR11468; PTHR11468; 1.
DR   Pfam; PF00343; Phosphorylase; 1.
DR   PIRSF; PIRSF000460; Pprylas_GlgP; 1.
DR   TIGRFAMs; TIGR02093; P_ylase; 1.
DR   PROSITE; PS00102; PHOSPHORYLASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Allosteric enzyme; Alternative splicing;
KW   Carbohydrate metabolism; Complete proteome; Disease mutation;
KW   Glycogen metabolism; Glycogen storage disease; Glycosyltransferase;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Pyridoxal phosphate;
KW   Reference proteome; Transferase.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330}.
FT   CHAIN         2    847       Glycogen phosphorylase, liver form.
FT                                /FTId=PRO_0000188524.
FT   BINDING      76     76       AMP. {ECO:0000250}.
FT   SITE        109    109       Involved in the association of subunits.
FT                                {ECO:0000250}.
FT   SITE        143    143       Involved in the association of subunits.
FT                                {ECO:0000250}.
FT   SITE        156    156       May be involved in allosteric control.
FT                                {ECO:0000250}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES      15     15       Phosphoserine; by PHK; in form
FT                                phosphorylase A.
FT                                {ECO:0000269|PubMed:10949035}.
FT   MOD_RES     204    204       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P09812}.
FT   MOD_RES     227    227       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P09812}.
FT   MOD_RES     364    364       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9ET01}.
FT   MOD_RES     430    430       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9WUB3}.
FT   MOD_RES     524    524       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9ET01}.
FT   MOD_RES     561    561       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P09811}.
FT   MOD_RES     639    639       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     681    681       N6-(pyridoxal phosphate)lysine.
FT                                {ECO:0000250}.
FT   VAR_SEQ      82    115       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045339.
FT   VARIANT     222    222       V -> I (in dbSNP:rs946616).
FT                                {ECO:0000269|PubMed:9529348}.
FT                                /FTId=VAR_007907.
FT   VARIANT     231    231       V -> E (in dbSNP:rs1042195).
FT                                /FTId=VAR_013095.
FT   VARIANT     339    339       N -> S (in GSD6; dbSNP:rs113993976).
FT                                {ECO:0000269|PubMed:9529348}.
FT                                /FTId=VAR_007908.
FT   VARIANT     377    377       N -> K (in GSD6; dbSNP:rs113993977).
FT                                {ECO:0000269|PubMed:9529348}.
FT                                /FTId=VAR_007909.
FT   VARIANT     425    425       R -> P (in dbSNP:rs2228499).
FT                                {ECO:0000269|PubMed:2877458}.
FT                                /FTId=VAR_034425.
FT   VARIANT     698    698       V -> G (in dbSNP:rs35831273).
FT                                /FTId=VAR_034426.
FT   VARIANT     715    715       R -> S (in dbSNP:rs1042210).
FT                                /FTId=VAR_013096.
FT   VARIANT     806    806       I -> L (in dbSNP:rs34313873).
FT                                /FTId=VAR_034427.
FT   VARIANT     845    845       N -> S (in dbSNP:rs78558135).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_069054.
FT   CONFLICT      2      3       AK -> GE (in Ref. 1; AAA52577 and 3;
FT                                AAC18079). {ECO:0000305}.
FT   CONFLICT     83     83       V -> E (in Ref. 1; AAA52577).
FT                                {ECO:0000305}.
FT   CONFLICT    323    323       A -> Q (in Ref. 1; AAA52577).
FT                                {ECO:0000305}.
FT   CONFLICT    344    345       AL -> RI (in Ref. 1; AAA52577).
FT                                {ECO:0000305}.
FT   CONFLICT    369    369       T -> N (in Ref. 1; AAA52577 and 3;
FT                                AAC18079). {ECO:0000305}.
FT   CONFLICT    570    570       R -> S (in Ref. 2; AAC17450).
FT                                {ECO:0000305}.
FT   CONFLICT    683    683       Missing (in Ref. 8; AAH09895).
FT                                {ECO:0000305}.
FT   CONFLICT    715    715       R -> G (in Ref. 5; BAG62279).
FT                                {ECO:0000305}.
FT   TURN          8     10       {ECO:0000244|PDB:1FA9}.
FT   HELIX        11     13       {ECO:0000244|PDB:1FA9}.
FT   STRAND       14     17       {ECO:0000244|PDB:1FA9}.
FT   HELIX        19     38       {ECO:0000244|PDB:3DDS}.
FT   HELIX        44     46       {ECO:0000244|PDB:3DDS}.
FT   HELIX        49     62       {ECO:0000244|PDB:3DDS}.
FT   HELIX        65     78       {ECO:0000244|PDB:3DDS}.
FT   STRAND       82     86       {ECO:0000244|PDB:3DDS}.
FT   STRAND       90     93       {ECO:0000244|PDB:3DDS}.
FT   HELIX        96    102       {ECO:0000244|PDB:3DDS}.
FT   HELIX       106    115       {ECO:0000244|PDB:3DDS}.
FT   HELIX       120    125       {ECO:0000244|PDB:3DDS}.
FT   STRAND      130    135       {ECO:0000244|PDB:3DDS}.
FT   HELIX       136    150       {ECO:0000244|PDB:3DDS}.
FT   STRAND      155    160       {ECO:0000244|PDB:3DDS}.
FT   STRAND      168    172       {ECO:0000244|PDB:3DDS}.
FT   STRAND      175    179       {ECO:0000244|PDB:3DDS}.
FT   TURN        183    186       {ECO:0000244|PDB:3DDS}.
FT   HELIX       195    197       {ECO:0000244|PDB:3DDS}.
FT   STRAND      199    204       {ECO:0000244|PDB:3DDS}.
FT   STRAND      206    210       {ECO:0000244|PDB:3DDS}.
FT   STRAND      213    218       {ECO:0000244|PDB:3DDS}.
FT   STRAND      220    232       {ECO:0000244|PDB:3DDS}.
FT   STRAND      234    237       {ECO:0000244|PDB:1L5S}.
FT   STRAND      239    248       {ECO:0000244|PDB:3DDS}.
FT   HELIX       255    260       {ECO:0000244|PDB:1FA9}.
FT   HELIX       263    268       {ECO:0000244|PDB:3DDS}.
FT   HELIX       270    274       {ECO:0000244|PDB:3DDS}.
FT   HELIX       275    277       {ECO:0000244|PDB:3DDS}.
FT   HELIX       291    314       {ECO:0000244|PDB:3DDS}.
FT   STRAND      315    317       {ECO:0000244|PDB:1FA9}.
FT   STRAND      322    325       {ECO:0000244|PDB:3DDW}.
FT   HELIX       327    329       {ECO:0000244|PDB:1L5R}.
FT   HELIX       330    333       {ECO:0000244|PDB:3DDS}.
FT   STRAND      334    341       {ECO:0000244|PDB:3DDS}.
FT   TURN        342    345       {ECO:0000244|PDB:3DDS}.
FT   HELIX       346    356       {ECO:0000244|PDB:3DDS}.
FT   HELIX       362    372       {ECO:0000244|PDB:3DDS}.
FT   STRAND      373    376       {ECO:0000244|PDB:3DDS}.
FT   HELIX       382    384       {ECO:0000244|PDB:3DDS}.
FT   STRAND      387    389       {ECO:0000244|PDB:3DDS}.
FT   HELIX       390    396       {ECO:0000244|PDB:3DDS}.
FT   HELIX       398    418       {ECO:0000244|PDB:3DDS}.
FT   STRAND      419    421       {ECO:0000244|PDB:3CEJ}.
FT   HELIX       423    429       {ECO:0000244|PDB:3DDS}.
FT   STRAND      431    433       {ECO:0000244|PDB:3DDS}.
FT   STRAND      435    437       {ECO:0000244|PDB:3DDS}.
FT   STRAND      439    441       {ECO:0000244|PDB:3DDS}.
FT   HELIX       442    448       {ECO:0000244|PDB:3DDS}.
FT   STRAND      451    457       {ECO:0000244|PDB:3DDS}.
FT   HELIX       458    466       {ECO:0000244|PDB:3DDS}.
FT   TURN        467    469       {ECO:0000244|PDB:3DDS}.
FT   HELIX       470    475       {ECO:0000244|PDB:3DDS}.
FT   HELIX       477    479       {ECO:0000244|PDB:3DDS}.
FT   STRAND      480    482       {ECO:0000244|PDB:3DDS}.
FT   HELIX       490    495       {ECO:0000244|PDB:3DDS}.
FT   HELIX       498    508       {ECO:0000244|PDB:3DDS}.
FT   HELIX       511    513       {ECO:0000244|PDB:3DDS}.
FT   HELIX       516    525       {ECO:0000244|PDB:3DDS}.
FT   HELIX       529    553       {ECO:0000244|PDB:3DDS}.
FT   STRAND      554    556       {ECO:0000244|PDB:1L5R}.
FT   STRAND      562    569       {ECO:0000244|PDB:3DDS}.
FT   TURN        573    576       {ECO:0000244|PDB:3DDS}.
FT   HELIX       577    593       {ECO:0000244|PDB:3DDS}.
FT   STRAND      595    597       {ECO:0000244|PDB:3CEJ}.
FT   STRAND      602    607       {ECO:0000244|PDB:3DDS}.
FT   HELIX       615    633       {ECO:0000244|PDB:3DDS}.
FT   TURN        635    637       {ECO:0000244|PDB:3DDS}.
FT   HELIX       638    640       {ECO:0000244|PDB:3DDS}.
FT   STRAND      641    646       {ECO:0000244|PDB:3DDS}.
FT   HELIX       651    657       {ECO:0000244|PDB:3DDS}.
FT   HELIX       658    660       {ECO:0000244|PDB:3DDS}.
FT   STRAND      662    666       {ECO:0000244|PDB:3DDS}.
FT   TURN        670    672       {ECO:0000244|PDB:2ATI}.
FT   HELIX       678    684       {ECO:0000244|PDB:3DDS}.
FT   STRAND      688    691       {ECO:0000244|PDB:3DDS}.
FT   HELIX       697    704       {ECO:0000244|PDB:3DDS}.
FT   HELIX       706    708       {ECO:0000244|PDB:3DDS}.
FT   STRAND      709    711       {ECO:0000244|PDB:3DDS}.
FT   HELIX       716    725       {ECO:0000244|PDB:3DDS}.
FT   HELIX       729    735       {ECO:0000244|PDB:3DDS}.
FT   HELIX       737    748       {ECO:0000244|PDB:3DDS}.
FT   TURN        749    751       {ECO:0000244|PDB:3DDS}.
FT   TURN        756    759       {ECO:0000244|PDB:3DDS}.
FT   HELIX       760    768       {ECO:0000244|PDB:3DDS}.
FT   HELIX       774    792       {ECO:0000244|PDB:3DDS}.
FT   HELIX       795    806       {ECO:0000244|PDB:3DDS}.
FT   HELIX       810    812       {ECO:0000244|PDB:3DDS}.
FT   HELIX       814    824       {ECO:0000244|PDB:3DDS}.
SQ   SEQUENCE   847 AA;  97149 MW;  74017E8125FB5735 CRC64;
     MAKPLTDQEK RRQISIRGIV GVENVAELKK SFNRHLHFTL VKDRNVATTR DYYFALAHTV
     RDHLVGRWIR TQQHYYDKCP KRVYYLSLEF YMGRTLQNTM INLGLQNACD EAIYQLGLDI
     EELEEIEEDA GLGNGGLGRL AACFLDSMAT LGLAAYGYGI RYEYGIFNQK IRDGWQVEEA
     DDWLRYGNPW EKSRPEFMLP VHFYGKVEHT NTGTKWIDTQ VVLALPYDTP VPGYMNNTVN
     TMRLWSARAP NDFNLRDFNV GDYIQAVLDR NLAENISRVL YPNDNFFEGK ELRLKQEYFV
     VAATLQDIIR RFKASKFGST RGAGTVFDAF PDQVAIQLND THPALAIPEL MRIFVDIEKL
     PWSKAWELTQ KTFAYTNHTV LPEALERWPV DLVEKLLPRH LEIIYEINQK HLDRIVALFP
     KDVDRLRRMS LIEEEGSKRI NMAHLCIVGS HAVNGVAKIH SDIVKTKVFK DFSELEPDKF
     QNKTNGITPR RWLLLCNPGL AELIAEKIGE DYVKDLSQLT KLHSFLGDDV FLRELAKVKQ
     ENKLKFSQFL ETEYKVKINP SSMFDVQVKR IHEYKRQLLN CLHVITMYNR IKKDPKKLFV
     PRTVIIGGKA APGYHMAKMI IKLITSVADV VNNDPMVGSK LKVIFLENYR VSLAEKVIPA
     TDLSEQISTA GTEASGTGNM KFMLNGALTI GTMDGANVEM AEEAGEENLF IFGMRIDDVA
     ALDKKGYEAK EYYEALPELK LVIDQIDNGF FSPKQPDLFK DIINMLFYHD RFKVFADYEA
     YVKCQDKVSQ LYMNPKAWNT MVLKNIAASG KFSSDRTIKE YAQNIWNVEP SDLKISLSNE
     SNKVNGN
//
